Albiglutide, a Long Lasting Glucagon-Like Peptide-1 Analog, Protects the Rat Heart against Ischemia/Reperfusion Injury: Evidence for Improving Cardiac Metabolic Efficiency-Reference-Cited by-同舟云学术

Albiglutide, a Long Lasting Glucagon-Like Peptide-1 Analog, Protects the Rat Heart against Ischemia/Reperfusion Injury: Evidence for Improving Cardiac Metabolic Efficiency

Published:2011-08-26 Issue:8 Volume:6 Page:e23570
ISSN:1932-6203
Container-title:PLoS ONE
language:en
Short-container-title:PLoS ONE

Author:

Bao Weike,Aravindhan Karpagam,Alsaid Hasan,Chendrimada Thimmaiah,Szapacs Matthew,Citerone David R.,Harpel Mark R.,Willette Robert N.,Lepore John J.,Jucker Beat M.

Publisher

Public Library of Science (PLoS)

Subject

Multidisciplinary

Reference38 articles.

1. Biology of incretins GLP-1 and GIP.;LL Baggio;Gastroenterology,2007

2. New treatments in type 2 diabetes: a focus on the incretin-based therapies.;AH Barnett;Clin Endocrinol (Oxf),2009

3. Emerging cardiovascular actions of the incretin hormone glucagon-like peptide-1: potential therapeutic benefits beyond glycaemic control?;DJ Grieve;Br J Pharmacol,2009

4. Glucagon like peptide-1 is protective against myocardial ischemia/reperfusion injury when given either as a preconditioning mimetic or at reperfusion in an isolated rat heart model.;AK Bose;Cardiovasc Drugs Ther,2005

5. Glucagon-like peptide 1 can directly protect the heart against ischemia/reperfusion injury.;AK Bose;Diabetes,2005

Cited by 88 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Cocaine and amphetamine‐regulated transcript improves myocardial ischemia–reperfusion injury through PI3K/AKT signalling pathway;Clinical and Experimental Pharmacology and Physiology;2024-06-23

2. Glucagon-like peptide-1 receptor agonists and sodium-glucose cotransporter 2 inhibitors, anti-diabetic drugs in heart failure and cognitive impairment: potential mechanisms of the protective effects;Frontiers in Pharmacology;2024-06-14

3. Peptides Are Cardioprotective Drugs of the Future: The Receptor and Signaling Mechanisms of the Cardioprotective Effect of Glucagon-like Peptide-1 Receptor Agonists;International Journal of Molecular Sciences;2024-04-30

4. Potential Role of GLP-1 Based Therapeutics in Coronary Artery Disease;Frontiers in Bioscience-Landmark;2023-11-29

5. Diabetes Mellitus in Acute Coronary Syndrome;Life;2023-11-19